A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-07-16) →
What happened
Orion disclosed a subsidiary's acquisition of LigaChem Biosciences Co., Ltd., worth US$53.3M.
For context, this deal is worth about 1.8% of the company's consolidated total assets.
| Target | LigaChem Biosciences Co., Ltd. |
|---|---|
| Deal value | US$53.3M |
| vs. company assets | 1.8% |
| Filed | 2026-06-26, Decision to acquire shares/equity in another company (voluntary) (subsidiary) |
| Source | DART rcept 20260626800014 → open original filing |
Versions of this filing
- 2026-06-26Original (this page)
- 2026-07-16Amendment 1
Source: DART. Information only, not investment advice.